BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 36253712)

  • 1. Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta.
    Nathania I; Nainggolan IM; Yasmon A; Nusatia ACM; Tjoa E; Gunardi WD; Moehario LH
    BMC Microbiol; 2022 Oct; 22(1):250. PubMed ID: 36253712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
    Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
    J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
    Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
    Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
    Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
    Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of resistant mutants of Salmonella enterica serotype Typhi under ciprofloxacin selective pressure.
    Dahiya S; Kapil A; Lodha R; Kumar R; Das BK; Sood S; Kabra SK
    Indian J Med Res; 2014 May; 139(5):746-53. PubMed ID: 25027085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.
    Ling JM; Chan EW; Lam AW; Cheng AF
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3567-73. PubMed ID: 14576119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics in adult patients with Salmonella bacteremia and analysis of ciprofloxacin-nonsusceptible isolates.
    Cheng MW; Lee CM; Wang NY; Wu AY; Lin CC; Weng LC; Liu CP; Shih SC
    J Microbiol Immunol Infect; 2015 Dec; 48(6):692-8. PubMed ID: 26542649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.
    Pérez-Vázquez M; Román F; Aracil B; Cantón R; Campos J
    J Clin Microbiol; 2004 Mar; 42(3):1185-91. PubMed ID: 15004073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica.
    Eaves DJ; Randall L; Gray DT; Buckley A; Woodward MJ; White AP; Piddock LJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4012-5. PubMed ID: 15388468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Italy.
    García-Fernández A; Gallina S; Owczarek S; Dionisi AM; Benedetti I; Decastelli L; Luzzi I
    PLoS One; 2015; 10(6):e0132065. PubMed ID: 26121266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A.
    Hirose K; Hashimoto A; Tamura K; Kawamura Y; Ezaki T; Sagara H; Watanabe H
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3249-52. PubMed ID: 12234852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
    Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
    J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal and plasmid-mediated fluoroquinolone resistance in human Salmonella enterica infection in Ghana.
    Acheampong G; Owusu M; Owusu-Ofori A; Osei I; Sarpong N; Sylverken A; Kung HJ; Cho ST; Kuo CH; Park SE; Marks F; Adu-Sarkodie Y; Owusu-Dabo E
    BMC Infect Dis; 2019 Oct; 19(1):898. PubMed ID: 31660876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.
    Chau TT; Campbell JI; Galindo CM; Van Minh Hoang N; Diep TS; Nga TT; Van Vinh Chau N; Tuan PQ; Page AL; Ochiai RL; Schultsz C; Wain J; Bhutta ZA; Parry CM; Bhattacharya SK; Dutta S; Agtini M; Dong B; Honghui Y; Anh DD; Canh DG; Naheed A; Albert MJ; Phetsouvanh R; Newton PN; Basnyat B; Arjyal A; La TT; Rang NN; Phuong LT; Van Be Bay P; von Seidlein L; Dougan G; Clemens JD; Vinh H; Hien TT; Chinh NT; Acosta CJ; Farrar J; Dolecek C
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4315-23. PubMed ID: 17908946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of seven novel mutations of gyrB, parC and parE in Salmonella Typhi and Paratyphi strains from Jiangsu Province of China.
    Qian H; Cheng S; Liu G; Tan Z; Dong C; Bao J; Hong J; Jin D; Bao C; Gu B
    Sci Rep; 2020 Apr; 10(1):7359. PubMed ID: 32355184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
    Lee CJ; Su LH; Huang YC; Chiu CH
    J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.